0001140361-22-044639.txt : 20221206
0001140361-22-044639.hdr.sgml : 20221206
20221206210208
ACCESSION NUMBER: 0001140361-22-044639
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221202
FILED AS OF DATE: 20221206
DATE AS OF CHANGE: 20221206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cherington Charles
CENTRAL INDEX KEY: 0001448698
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11460
FILM NUMBER: 221448981
MAIL ADDRESS:
STREET 1: ONE BOW STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eterna Therapeutics Inc.
CENTRAL INDEX KEY: 0000748592
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 311103425
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10355 SCIENCE CENTER DRIVE
STREET 2: SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (212) 582-1199
MAIL ADDRESS:
STREET 1: 10355 SCIENCE CENTER DRIVE
STREET 2: SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc.
DATE OF NAME CHANGE: 20210325
FORMER COMPANY:
FORMER CONFORMED NAME: NTN BUZZTIME INC
DATE OF NAME CHANGE: 20051230
FORMER COMPANY:
FORMER CONFORMED NAME: NTN COMMUNICATIONS INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
X0306
4
2022-12-02
0000748592
Eterna Therapeutics Inc.
ERNA
0001448698
Cherington Charles
C/O ETERNA THERAPEUTICS INC.
10355 SCIENCE CENTER DRIVE, SUITE 150
SAN DIEGO
CA
92121
true
true
Common Stock
2022-12-02
4
P
0
261756
3.28
A
556465
D
Warrants (right to buy)
3.28
2022-12-02
4
P
0
523512
0.125
A
2023-06-02
2028-06-02
Common Stock, par value $0.005 per share
523512
523512
D
The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 261,756 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules.
/s/ Sandra Gurrola, Power of Attorney for Charles Cherington
2022-12-06